Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

European AIDS Ambassadors Come to Washington

Recognizing that a global epidemic requires a global response, 5 European AIDS Ambassadors came to Washington this week to strengthen transatlantic cooperation in the global fight against HIV/AIDS. At a public event co-sponsored by CGD and CSIS, Ambassadors from Belgium, France, Norway, the Netherlands, and Sweden emphasized that European and American policymakers largely agreed on how AIDS programs should be designed and delivered.

Hundreds of Thousands Saved: A Measles Success Story

The numbers are in! The Measles Initiative, which set out to halve the global measles burden between 1999 and 2005, has surpassed its goal with a 60 percent reduction. A new Lancet study (subscription required) reports an estimated drop in measles deaths from 873,000 in 1999 to 345,000 in 2005 (based on a natural history model to evaluate mortality trends).

Budget Cuts & Lost Trust

In spite of the endless analysis and hovering media attention during the new Congress's "100 hours," one of the first major budget decisions has somehow gone largely unnoticed: the Democrats decided to nix the Republican's 2007 budget request and continue funding programs at FY06 levels. As Desmond Tutu wrote in Monday's Washington Post, the effects of this decision could be tragic for many Africans infected or affected by HIV/AIDS:

Budget Cuts & Lost Trust

In spite of the endless analysis and hovering media attention during the new Congress's "100 hours," one of the first major budget decisions has somehow gone largely unnoticed: the Democrats decided to nix the Republican's 2007 budget request and continue funding programs at FY06 levels. As Desmond Tutu wrote in Monday's Washington Post, the effects of this decision could be tragic for many Africans infected or affected by HIV/AIDS:

Outwitting & Outwaiting ARV Resistance

In the best health news of the year (so far!), a new New England Journal of Medicine study has found that delaying the start of a nevirapine-based antiretroviral therapy by six months can prevent the development of drug resistance in HIV-positive women who took single-dose nevirapine during labor to prevent mother-to-child transmission of the virus.

Outwitting & Outwaiting ARV Resistance

In the best health news of the year (so far!), a new New England Journal of Medicine study has found that delaying the start of a nevirapine-based antiretroviral therapy by six months can prevent the development of drug resistance in HIV-positive women who took single-dose nevirapine during labor to prevent mother-to-child transmission of the virus.

Pages